All Cosmos Bio-Tech Holding Limited (4148)
TWSE
32.40
+1.25 (+4.01%)
Closed
Sep 10, 2026
Day's Range
32.1533.85
52 wk Range
29.2544.90
Financial Statements - 4148 - All Cosmos Bio-Tech Holding Limited
Revenue
2.94B▲ 19.9%
Net Income
206.22M▲ 18.2%Net Margin 7.0%
EBITDA
385.08M▲ 20.1%
Free Cash Flow
209.13M▲ 337.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 2.94B | 2.45B | 2.82B | 3.70B | 2.19B | 1.64B |
| Cost of Goods | 2.11B | 1.79B | 2.23B | 2.56B | 1.60B | 1.27B |
| Gross Profit | 829.47M | 668.59M | 587.97M | 1.13B | 594.36M | 372.14M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 303.66M | 163.71M | 187.89M | 659.73M | 212.73M | 95.08M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 297.37M | 252.77M | 257.63M | 633.95M | 321.58M | 149.67M |
| Income Tax | 91.14M | 78.28M | 68.32M | 177.93M | 84.93M | 51.50M |
| Net Income | 206.22M | 174.49M | 189.30M | 456.01M | 236.65M | 98.16M |
| EPS Basic | 2.28 | 1.914286 | 2.18 | 5.75 | 3.09 | 1.28 |
| EPS Diluted | 2.27 | 1.847619 | 2.13 | 5.65 | 3.09 | 1.28 |
| Basic Shares Outstanding | 67.23M | 67.23M | 64.03M | 64.03M | 64.03M | 64.03M |
| Diluted Shares Outstanding | 67.23M | 67.23M | 64.03M | 64.03M | 64.03M | 64.03M |
| Ebit | 311.90M | 258.85M | 261.61M | 652.76M | 326.12M | 154.11M |
| Ebitda | 385.08M | 320.66M | 308.76M | 694.51M | 314.20M | 196.63M |
| Net Income Continuous Operations | 297.37M | 252.77M | 257.63M | 633.95M | 321.58M | 149.67M |
| Minority Interests | -53.22M | -45.90M | -49.94M | -87.81M | -38.52M | -15.96M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
